We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$731M
AUM Growth
-$60.4M
Cap. Flow
-$453M
Cap. Flow %
-62.05%
Top 10 Hldgs %
62.84%
Holding
133
New
81
Increased
1
Reduced
15
Closed
33
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COOLU
26
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
$5.14M 0.7%
+491,503
New +$5.1M
KINZU
27
DELISTED
KINS Technology Group Inc. Unit
KINZU
$4.97M 0.68%
+483,310
New +$4.97M
TMTS
28
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$4.94M 0.68%
+490,662
New +$4.88M
ACACU
29
DELISTED
Acies Acquisition Corp Unit
ACACU
$4.82M 0.66%
+450,000
New +$4.58M
ARBGU
30
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$4.17M 0.57%
+413,194
New +$4.15M
JSPR icon
31
Jasper Therapeutics
JSPR
$20.5M
$4.06M 0.56%
+40,555
New +$4.04M
ALUS
32
DELISTED
Alussa Energy Acquisition Corp
ALUS
$3.86M 0.53%
+383,330
New +$3.82M
VHC icon
33
VirnetX Holding Corp
VHC
$54M
$3.75M 0.51%
37,192
-46,676
-56% -$5.04M
ASAQ
34
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$3.72M 0.51%
+369,396
New +$3.61M
EDTXU
35
DELISTED
EdtechX Holdings Acquisition Corp. II Unit
EDTXU
$3.69M 0.51%
+357,962
New +$3.66M
SXC icon
36
SunCoke Energy
SXC
$783M
$3.69M 0.51%
848,624
-4,216,139
-83% -$17.6M
ABX
37
Abacus Global Management
ABX
$1B
$3.3M 0.45%
+325,011
New +$3.19M
COLL icon
38
Collegium Pharmaceutical
COLL
$1.16B
$3.25M 0.44%
162,003
-431,738
-73% -$8.43M
MAAC
39
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
$3.19M 0.44%
+314,040
New +$3.16M
ETAC
40
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$3.19M 0.44%
+311,672
New +$3.07M
LNFA.U
41
DELISTED
L&F Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one rede
LNFA.U
$3.15M 0.43%
+303,528
New +$3.09M
CAP.U
42
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
$3.09M 0.42%
+299,850
New +$3.06M
HCARU
43
DELISTED
Healthcare Services Acquisition Corporation Unit
HCARU
$3.07M 0.42%
+300,000
New +$3.08M
PMVC.U
44
DELISTED
PMV Consumer Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PMVC.U
$3.02M 0.41%
+293,232
New +$2.95M
FST
45
DELISTED
FAST Acquisition Corp.
FST
$2.98M 0.41%
+291,053
New +$2.85M
BLUWU
46
DELISTED
Blue Water Acquisition Corp. Unit
BLUWU
$2.96M 0.4%
+285,460
New +$2.92M
GOAC
47
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$2.78M 0.38%
+272,648
New +$2.68M
ASPL.U
48
DELISTED
Aspirational Consumer Lifestyle Corp. Units, each consisting of one Class A ordinary share and one-t
ASPL.U
$2.75M 0.38%
+262,757
New +$2.65M
HPX
49
DELISTED
HPX Corp.
HPX
$2.74M 0.37%
+273,238
New +$2.68M
AMR icon
50
Alpha Metallurgical Resources
AMR
$1.85B
$2.69M 0.37%
236,745
-357,852
-60% -$3.21M

Similar funds

Mangrove Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Mangrove Partners held 133 positions worth $731M, down 7.6% from $791M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Mangrove Partners withdrew a net $453M in Q4 2020, closing 33 positions and reducing 15 holdings. Its most notable exit was PG&E, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Mangrove Partners opened a new position in ScION Tech Growth I Unit worth $11.5M.

  • Mangrove Partners's largest Q4 2020 buy was ScION Tech Growth I Unit: 1,114,998 shares worth $11.5M.
  • Mangrove Partners added most to Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, an estimated $9.18M increase.
  • Mangrove Partners's biggest Q4 2020 reduction was Civitas Resources, cutting an estimated $35.1M.
  • Mangrove Partners fully exited PG&E in Q4 2020, selling an estimated $43.2M.
  • Mangrove Partners's ten largest holdings make up 63% of its $731M portfolio in Q4 2020.
  • Mangrove Partners opened 81 new positions and closed 33 in Q4 2020.
  • Mangrove Partners's portfolio value fell 7.6% quarter-over-quarter to $731M.

Based on Mangrove Partners's 13F filing for Q4 2020, filed 16 Feb 2021.